Macleods Pharmaceuticals is recalling about 10,000 bottles of generic antibiotic medication in the U.S. market due to a labelling error, according to the U.S. health regulator.
As per the latest enforcement report by the U.S. Food and Drug Administration (U.S.FDA), Macleods Pharma Inc., a U.S-based unit of the company, is recalling 10,052 bottles of Levofloxacin tablets, which are used to treat different types of bacterial infections.
The company is recalling the affected lot due to"mismatching of the embossing on the tablets with the embossing mentioned in the package insert in the distributed bottles." Macleods manufactured the affected lot in its Baddi-based manufacturing plant in Himachal Pradesh.
The company initiated the Class III recall in the U.S. and Puerto Rico on January 5.
As per the USFDA, a Class III recall is initiated in a “situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.”
The U.S. generic drug market was estimated to be around $115.2 billion in 2019. It is by far the largest market for pharmaceutical products in the world.
In the last financial year, India's pharma exports stood at about $24.62 billion with the U.S., the U.K., South Africa, Russia, and Nigeria emerging as the top five destinations.
The Mumbai-based company has presence across various therapeutic segments including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment.
